Andrea Kelly is an Endocrinology/Metabolic physician affiliated with Children's Hospital of Philadelphia. OpenAlex indexes 493 publications with 8,422 citations (h-index 51); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3401 Civic Center Blvd
Children'S Hospital Of Philadelphia - Endocrinology
Philadelphia, PA 191044319
Telephone
215-590-3174Registry record last updated 15 Apr 2013.
Clinical trials
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Sponsor: University of Pennsylvania
- Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)
Sponsor: Children's Hospital of Philadelphia
- Genetics of Insulin and Incretins in Cystic Fibrosis
Sponsor: Children's Hospital of Philadelphia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%alpha-Glucosidase Inhibitor100%Acarbose100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
11 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Advancing the Lives & HeaLth of Youth and Young Adults with Down Syndrome (ALLY-DS)
Children'S Hosp of Philadelphia
FY2026$2,008,376U01HD116470 - Translational Research Training in Pediatric Diabetes & Endocrinology
Children'S Hosp of Philadelphia
FY2026$243,991T32DK063688 - PARTNERS: Program to Advance Research and Transdisciplinary TraiNing in the CarE of PeRsons with Down Syndrome
Children'S Hosp of Philadelphia
FY2025$732,541R25HD118212
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Grupp, MD
Children's Hospital of Philadelphia
John Maris, MD
Children's Hospital of Philadelphia
Stephen Hunger, MD
Children's Hospital of Philadelphia
Jonathan Spergel, MD
Children's Hospital of Philadelphia
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”